Royal Bank Of Canada Renalytix PLC Transaction History

Royal Bank Of Canada

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.23 - $0.93 $10 - $40	-44 Reduced 68.75%	20 $0
Q1 2024 Nov 05, 2024	BUY	$0.26 - $1.47 $11 - $64	44 Added 220.0%	64 $0
Q4 2023 Feb 14, 2024	BUY	$0.33 - $1.61 $21 - $103	64 New	64 $0
Q2 2023 Aug 14, 2023	BUY	$2.0 - $2.92 $40,000 - $58,400	20,000 New	20,000 $58,000
Q2 2022 Aug 15, 2022	BUY	$2.45 - $7.81 $2,205 - $7,029	900 Added 66.67%	2,250 $6,000
Q1 2022 May 16, 2022	SELL	$5.88 - $15.9 $2,352 - $6,360	-400 Reduced 22.86%	1,350 $10,000
Q4 2021 Feb 14, 2022	BUY	$13.43 - $27.4 $14,101 - $28,770	1,050 Added 150.0%	1,750 $28,000
Q3 2021 Nov 15, 2021	BUY	$17.91 - $34.78 $11,945 - $23,198	667 Added 2021.21%	700 $14,000
Q2 2021 Aug 16, 2021	BUY	$23.56 - $34.25 $777 - $1,130	33 New	33 $1,000

554K

Ticker RNLX
Exchange OTC
Sector Healthcare
Industry Health Information Services
Shares Outstandng 37,445,900
Market Cap $5.62M
Description
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.